Federal Register
Notice: FDA has submitted a proposed collection of information, Draft Guidance for Industry and FDA Staff on Class II Special Controls Guidance Document: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle, to the Office of Management and Budget for review and clearance. To view this notice, click here.